Medical news network February 10th February 9th, the State Food and Drug Administration issued "on the 54 batches of substandard Chinese herbal medicine notice (2017 No. twenty-first)", involving 46 companies a total of 54 batches of Chinese herbal medicine was put on the black list". At the same time, the 46 companies have been sentenced to criminal investigation.
According to the notice of the content display, unqualified varieties concentrated in isatis root, angelica, Magnolia, Magnolia, scorpion (Jiang Houpu) 5, unqualified items including character, content, the amount of sulfur dioxide, extract etc.. On the 54 batches of substandard Chinese herbal pieces, the relevant provinces (autonomous regions and municipalities) food and drug administration has taken control measures such as seizure and seizure, requiring companies to suspend the sale of use, recall products, and rectification.
At the same time, the State Food and Drug Administration designated production enterprise of provinces (autonomous regions and municipalities) food and Drug Administration for the illegal production and sale of the company carried out an investigation of substandard products, make a decision on punishment in a month, report to the public administration and punishment. All penalties shall be punished to the responsible person.
Chinese herbal medicine man to storm
In recent years, Chinese herbal medicine, Chinese herbal medicine production and sale of counterfeit goods, dye doping, weight gain, the scope of business events emerge in an endless stream, have created more bad influence to the society, Chinese herbal medicine has become the focus of the flying no ground for blame. Especially as sulfur fumigation medicine, has seriously affected the quality of the products involved in this kind of raw material for pharmaceutical companies, pharmaceutical companies, and even to the downstream brings huge risk.
In two days ago (February 8th), the State Food and Drug Administration released the "2016 national drug GMP certificate to recover the tables" shows that in 2016 there are 162 pharmaceutical companies a total of 170 GMP certificates were recovered. Among them, there are 80 recovered GMP certificate from the Chinese herbal medicine enterprises, accounting for nearly 50% of the proportion. In 2015, the annual recovery of 82 pieces of Chinese herbal medicine, accounting for about 56.9% of the total. 2014 recovery of 20, accounting for 40% of the year's recovery. It can be seen that the Chinese herbal pieces are nearly three years of "big card", "hardest hit".
As the source of Chinese medicine, Chinese herbal medicine frequently problems, and how to protect the quality of Chinese medicine? Chinese herbal medicine and loopholes in the regulatory aspects, even has traced the dregs after counterfeiting enterprises to buy back to the market, impurities, shoddy, or half true half false, so the drug safety of patients is difficult to be guaranteed.
Currently, the State Food and drug administration frequently seized on the quality of Chinese herbal medicines, Chinese herbal pieces more stringent regulation. According to the State Food and drug administration official had introduced to the media, Chinese herbal medicine GMP certification inspection project is 111, of which 18 key projects, production procedures and key technology, production, storage and toxicity of Chinese herbal medicine packaging, processing standards, quality standards for production of water, Chinese herbal medicine prior to the release of the audit records are included in the key projects.
In July 2015, the State Ministry of Commerce issued the "Ministry of commerce market order our 2015 annual medicines and Chinese herbal medicine circulation online information service management system maintenance project bidding announcement", intends to launch Chinese herbal medicine circulation system. Meanwhile, over the past two years, many provinces have begun to publish a list of key pieces of Chinese herbal medicine, we can see the quality inspection and tracking of Chinese herbal medicines has become the norm.
It can be predicted that in the CFDA four most strict governance concept, the future for Chinese medicine, Chinese herbal medicine will be more severe regulation. |
